News

Filter

Current filters:

Grunenthal

1 to 9 of 26 results

Grünenthal Group appoints Sascha Becker as group chief financial officer

Grünenthal Group appoints Sascha Becker as group chief financial officer

20-10-2014

German pharma company Grünenthal Group has appointed Sascha Becker as group chief financial officer,…

BoardroomGermanyGrunenthalMerck SeronoPharmaceutical

AcelRx and Grunenthal file for EU approval of Zalviso

AcelRx and Grunenthal file for EU approval of Zalviso

07-07-2014

USA-based AcelRx Pharmaceuticals revealed this morning that its partner, family-owned German drugmaker…

AcelRxEuropeGrunenthalNeurologicalPharmaceuticalRegulationZalviso

Grunenthal tests innovative treatment in one of the largest clinical trials in cancer pain

Grunenthal tests innovative treatment in one of the largest clinical trials in cancer pain

10-06-2014

German family-owned drugmaker Grunenthal is investigating the efficacy and safety of the new analgesic…

cebranopadolGrunenthalMorphineNeurologicalOncologyPharmaceuticalResearch

Grunenthal strengthens pain product portfolio with European rights to etoricoxib

07-05-2014

Family-owned German drugmaker Grunenthal Group today announced the signing of an exclusive promotion…

etoricoxibEuropeGenericsGrunenthalLicensingMerck & CoNeurological

Grunenthal launches public tender offer to acquire Andromaco

04-12-2013

German family-owned drugmaker Grunenthal Group has now published its public tender offer to acquire all…

ChileGrunenthalLaboratorios AndromacoMergers & AcquisitionsPharmaceuticalSouth America

Grunenthal aims to strengthen Latin America business, appointing exec VP for the region; Novartis cancels Vasella deal

19-02-2013

German family-owned drugmaker Grunenthal Group announced the appointment of Oscar Ferenczi, former region…

GrunenthalManagementNovartisPharmaceutical

1 to 9 of 26 results

Back to top